Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

作者: Richard A Shlofmitz , Allen Jeremias , Thomas Pappas , Srihari S Naidu , Puja B Parikh

DOI:

关键词:

摘要: Bare-metal stent (BMS) use in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has been associated higher rates of adverse cardiac events, including target lesion and vessel revascularization. The purpose the present study was to determine which clinical characteristics predict BMS STEMI PCI. Data were prospectively collected from all who underwent PCI for between January 1, 2004 December 31, 2007 at four New York State academic medical centers. Demographics, baseline history, procedural characteristics, in-hospital outcomes compared receiving DESs versus BMSs. Of 1394 studied, a total 290 (20.8%) received while 1104 (79.2%) DES. Patients more likely have prior artery bypass graft surgery, PCI, peripheral vascular disease, diabetes mellitus, be Hispanic uninsured. They also thrombosis worse left ventricular ejection fraction (LVEF). had significantly longer hospital length stay trend toward all-cause mortality. In multivariate analysis, independent predictors included uninsured status (versus private insurance) (odds ratio [OR], 2.81; 95% confidence interval [CI], 1.70-4.67), disease (OR, 1.96; CI, 1.08- 3.56), LVEF 0.98; 0.97-0.99). conclusion, this analysis contemporary cohort lack health insurance, independently implantation

参考文章(21)
Ralf Birkemeyer, Waldemar Mielecki, Paweł Ranosz, Jacek S. Dubiel, Dariusz Dudek, Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry Clinical Research in Cardiology. ,vol. 100, pp. 139- 145 ,(2011) , 10.1007/S00392-010-0223-X
Vincenzo Pasceri, Giuseppe Patti, Giulio Speciale, Christian Pristipino, Giuseppe Richichi, Germano Di Sciascio, Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction American Heart Journal. ,vol. 153, pp. 749- 754 ,(2007) , 10.1016/J.AHJ.2007.02.016
Laura Mauri, Treacy S. Silbaugh, Pallav Garg, Robert E. Wolf, Katya Zelevinsky, Ann Lovett, Manu R. Varma, Zheng Zhou, Sharon-Lise T. Normand, Drug-eluting or bare-metal stents for acute myocardial infarction. The New England Journal of Medicine. ,vol. 359, pp. 1330- 1342 ,(2008) , 10.1056/NEJMOA0801485
Roxana Mehran, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, Fred Feit, E. Magnus Ohman, Helen Parise, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone, The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. American Heart Journal. ,vol. 156, pp. 44- 56 ,(2008) , 10.1016/J.AHJ.2008.02.008
Giuseppe De Luca, Gregg W. Stone, Harry Suryapranata, Gerrit Jan Laarman, Maurizio Menichelli, Christoph Kaiser, Marco Valgimigli, Emilio Di Lorenzo, Maurits T. Dirksen, Christian Spaulding, Undine Pittl, Roberto Violini, Gianfranco Percoco, Paolo Marino, Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials International Journal of Cardiology. ,vol. 133, pp. 213- 222 ,(2009) , 10.1016/J.IJCARD.2007.12.040
A. Kastrati, A. Dibra, C. Spaulding, G. J. Laarman, M. Menichelli, M. Valgimigli, E. Di Lorenzo, C. Kaiser, I. Tierala, J. Mehilli, M. Seyfarth, O. Varenne, M. T. Dirksen, G. Percoco, A. Varricchio, U. Pittl, M. Syvanne, M. J. Suttorp, R. Violini, A. Schomig, Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction European Heart Journal. ,vol. 28, pp. 2706- 2713 ,(2007) , 10.1093/EURHEARTJ/EHM402
Marie-Claude Morice, Patrick W. Serruys, J. Eduardo Sousa, Jean Fajadet, Ernesto Ban Hayashi, Marco Perin, Antonio Colombo, G. Schuler, Paul Barragan, Giulio Guagliumi, Ferenc Molnàr, Robert Falotico, A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization The New England Journal of Medicine. ,vol. 346, pp. 1773- 1780 ,(2002) , 10.1056/NEJMOA012843
Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, David R. Holmes, Charles O'Shaughnessy, Ronald P. Caputo, Dean J. Kereiakes, David O. Williams, Paul S. Teirstein, Judith L. Jaeger, Richard E. Kuntz, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine. ,vol. 349, pp. 1315- 1323 ,(2003) , 10.1056/NEJMOA035071
Gregg W. Stone, Alexandra J. Lansky, Stuart J. Pocock, Bernard J. Gersh, George Dangas, S. Chiu Wong, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Dariusz Dudek, Martin Möckel, Andrzej Ochala, Alison Kellock, Helen Parise, Roxana Mehran, Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. The New England Journal of Medicine. ,vol. 360, pp. 1946- 1959 ,(2009) , 10.1056/NEJMOA0810116